Provided By GlobeNewswire
Last update: Jun 5, 2025
SARASOTA, FL, June 05, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced that its Board of Directors has approved the purchase of up to $1 million in Bitcoin as a treasury reserve asset.
Read more at globenewswire.com0.5811
-0.06 (-9.2%)
Find more stocks in the Stock Screener
The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics.